“Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus”. Current Opinion in Endocrinology, Diabetes and Obesity14 (2): 98–107. (April 2007). doi:10.1097/MED.0b013e3280a02f65. PMID17940427.
Misumi Y, Hayashi Y, Arakawa F and Ikehara Y.(1992)"Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface."Biochim Biophys Acta1131,333-6. PMID1352704
“Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus”. Current Opinion in Endocrinology, Diabetes and Obesity14 (2): 98–107. (April 2007). doi:10.1097/MED.0b013e3280a02f65. PMID17940427.
Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C and Williams-Herman DE.(2006)"Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes."Diabetes Care29,2632-7. PMID17130196
Amori RE, Lau J and Pittas AG.(2007)"Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis."JAMA298,194-206. PMID17622601